The results that make headlines are built over months of consistent use, titrated doses, and lifestyle changes happening alongside the medication
One thing to watch for is a rise in blood pressure
Pfizer reported that its dose-optimization studies of once-daily formulations of danuglipron met key pharmacokinetic objectives and confirmed a formulation and dose with the potential to deliver a competitive efficacy and tolerability profile in Phase III testing, based on earlier studies of twice-daily danuglipron
Patients start with lower doses and gradually increase to the target therapeutic level
J Biol Chem 280:374239, PMID: 16144837 Allen JW, Shanker G, Aschner M (2001) Methylmercury inhibits the in vitro uptake of the glutathione precursor, cystine, in astrocytes, but not in neurons
This is crucial as low levels may slow down fat burning and energy production